Jyothy Laboratories reported a weak set of Q1 earnings. K Ullas Kamath, Joint MD and CFO of the company spoke about the results and his outlook for the company.
In July we were up by about 18 percent compared to July of earlier year, said Kamath.
However, wholesale is yet to recover in north and east India and similar situation was there during demonetisation, he added.
Jyothy Laboratories have 18.6 percent market share in mosquito coils business.
Will clarify on Henkel deal by October 31, Kamath added.
Watch accompanying video for more details.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
